13.49
Cullinan Therapeutics Inc Azioni (CGEM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
|
|
0.60%
55.26
|
55.59 | 75.80 | 55.00 | 48.85 |
| Operating Income/Loss |
0.60%
-55.26
|
-55.59 | -75.80 | -55.00 | -48.85 |
| Income/Loss From Continuing Operations Before Tax |
0.20%
-50.71
|
-50.61 | -70.06 | -48.50 | -40.56 |
| Income/Loss From Continuing Operations After Tax |
0.20%
-50.71
|
-50.61 | -70.06 | -48.50 | -40.56 |
|
|
0.20%
-50.71
|
-50.61 | -70.06 | -48.50 | -40.56 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):